Table 2.
The differences between the group being infected with Omicron and the group being infected with Delta in prevalence of different post-covid complaints over time
| Acute COVID-19 | Acute post-covid period | Sub-acute post-covid period | Chronic post-covid period | Whole post-covid period | |
|---|---|---|---|---|---|
| 1–13 days | 14–29 days | 30–89 days | 90 days and more | 14 to up to 126 days | |
| Any complaint | −49 | −4 | −20 | −43 | −23 |
| −83 to −15 | −36 to 28 | −46 to 5 | −72 to −14 | −46 to −1 | |
| Musculoskeletal pain | −18 | −7 | −2 | −23 | −9 |
| −40 to 4 | −28 to 14 | −19 to 15 | −43 to −2 | −24 to 6 | |
| Fatigue | 6 | 1 | −3 | −11 | −4 |
| −10 to 22 | −13 to 16 | −14 to 7 | −22 to 0 | −13 to 5 | |
| Cough | −10 | 3 | 1 | 4 | 2 |
| −21 to 1 | −5 to 11 | −4 to 5 | −2 to 11 | −2 to 6 | |
| Heart palpitations | −3 | 1 | −4 | −4 | −3 |
| −8 to 1 | −4 to 6 | −8 to −1 | −8 to 0 | −6 to 0 | |
| Shortness of breath | −8 | 0 | −3 | −3 | −3 |
| −14 to −3 | −7 to 6 | −8 to 1 | −8 to 1 | −7 to 1 | |
| Anxiety/depression | −15 | −2 | −9 | −5 | −7 |
| −32 to 1 | −18 to 14 | −22 to 4 | −20 to 10 | −19 to 5 | |
| Brain fog | −1 | −1 | 1 | −1 | 0 |
| −3 to 2 | −4 to 1 | −2 to 3 | −3 to 1 | −2 to 2 |
Estimates are group differences in prevalence per 10,000 persons in the respective groups, with 95% confidence intervals, representing the group testing positive with Omicron minus the group testing positive with Delta.